carbonthatcarbonthat
← Every fund

Virtus Biotech Etf

Filed by ETFis Series Trust I. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.

Positions
32
matched to a ticker
Fund size
$99.3M
the filing's own figure
Matched value
$44.8M
of the positions below
As of
2026-07-31
S000047354

What it holds

Largest share of the fund first.

Company% of fundValue
REGNRegeneron Pharmaceuticals Inc1.72%$1.7M
ACADACADIA Pharmaceuticals Inc1.69%$1.7M
BBIOBridgeBio Pharma Inc1.65%$1.6M
HALOHalozyme Therapeutics Inc1.64%$1.6M
ARWRArrowhead Pharmaceuticals Inc1.56%$1.5M
LGNDLigand Pharmaceuticals Inc1.55%$1.5M
ARQTArcutis Biotherapeutics Inc1.52%$1.5M
INCYIncyte Corp1.52%$1.5M
CYTKCytokinetics Inc1.51%$1.5M
MRNAModerna Inc1.51%$1.5M
AMGNAmgen Inc1.49%$1.5M
KRYSKrystal Biotech Inc1.48%$1.5M
VRTXVertex Pharmaceuticals Inc1.48%$1.5M
BMRNBioMarin Pharmaceutical Inc1.48%$1.5M
NBIXNeurocrine Biosciences Inc1.44%$1.4M
GILDGilead Sciences, Inc1.43%$1.4M
BCRXBioCryst Pharmaceuticals Inc1.42%$1.4M
RAREUltragenyx Pharmaceutical Inc1.41%$1.4M
AGIOAgios Pharmaceuticals Inc1.40%$1.4M
BIIBBiogen Inc1.40%$1.4M
IBRXImmunitybio Inc1.39%$1.4M
INSMInsmed Inc1.39%$1.4M
BNTXBiontech SE1.38%$1.4M
EXELExelixis Inc1.37%$1.4M
KURAKura Oncology Inc1.37%$1.4M
MDGLMadrigal Pharmaceuticals Inc1.34%$1.3M
SRPTSarepta Therapeutics Inc1.34%$1.3M
UTHRUnited Therapeutics Corp1.31%$1.3M
AXSMAxsome Therapeutics Inc1.18%$1.2M
NVAXNovavax Inc1.14%$1.1M
ALNYAlnylam Pharmaceuticals Inc1.00%$986.1K
IONSIonis Pharmaceuticals Inc0.97%$958.9K

Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.

Follow Virtus Biotech Etf by email

Virtus Biotech Etf's new holdings reports, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

Whale MovesAnyone crossing five per cent, and whether they want a say.Institutional HoldingsWhich funds own these companies, and what they changed.SectorsEvery company by sector and industry, with valuations.Stock ScreensPiotroski, Graham, dividend records and most shorted.